These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3942962)

  • 1. Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck.
    Maxim PE; Veltri RW
    Cancer; 1986 Jan; 57(2):305-11. PubMed ID: 3942962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of ferritin as a marker in head and neck malignancies.
    Bhatavdekar JM; Vora HH; Goyal A; Shah NG; Karelia NH; Trivedi SN
    Tumori; 1987 Feb; 73(1):59-63. PubMed ID: 3824534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
    Milman N; Pedersen LM
    Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of serum lipid profile and its prognostic value in head and neck squamous cell carcinoma.
    Li G; Da M; Zhang W; Wu H; Ye J; Chen J; Ma L; Gu N; Wu Y; Song X
    J Oral Pathol Med; 2016 Mar; 45(3):167-72. PubMed ID: 26189546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
    Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
    Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma.
    Gupta A; Kumar R; Sahu V; Agnihotri V; Singh AP; Bhasker S; Dey S
    Biochem Biophys Res Commun; 2015 Nov; 467(2):248-53. PubMed ID: 26435503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of serum ferritin level in potentially malignant disorders, oral squamous cell carcinoma, and treated cases of oral squamous cell carcinoma.
    Khanna V; Karjodkar F; Robbins S; Behl M; Arya S; Tripathi A
    J Cancer Res Ther; 2017; 13(3):550-555. PubMed ID: 28862225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of head and neck carcinomas by means of immunological tumour markers (Beta-2-microglobulin, immunoglobulin E, ferritin, N-acetyl-neuraminic acid, phosphohexose-isomerase).
    Vinzenz K; Schönthal E; Zekert F; Wunderer S
    J Craniomaxillofac Surg; 1987 Oct; 15(5):270-7. PubMed ID: 3316283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma.
    Mojtahedi Z; Khademi B; Yehya A; Talebi A; Fattahi MJ; Ghaderi A
    J Laryngol Otol; 2012 Feb; 126(2):175-9. PubMed ID: 21888745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new prognostic indicator for head and neck cancer--p53 serum antibodies?
    Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA
    Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
    Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ferritin levels in patients with cervical squamous cell carcinoma (author's transl)].
    Nomiyama H
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):245-9. PubMed ID: 7234335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ferritin: a tumor marker for renal cell carcinoma.
    Essen A; Ozen H; Ayhan A; Ergen A; Tasar C; Remzi F
    J Urol; 1991 Jun; 145(6):1134-7. PubMed ID: 2033679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
    Riedel F; Götte K; Schwalb J; Hörmann K
    Anticancer Res; 2000; 20(5A):3045-9. PubMed ID: 11062721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orosomucoid:prealbumin ratio--a marker of the host-tumor relationship in head and neck cancer.
    Caldani C; Thyss A; Schneider M; Milano G; Buray L; Demard F
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):653-7. PubMed ID: 3383968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.